Open Access

Effect of dexmedetomidine on preventing perioperative respiratory adverse events in children: A systematic review and meta‑analysis of randomized controlled trials

  • Authors:
    • Junli Zhang
    • Jing Yin
    • Yuanyuan Li
    • Yu Zhang
    • Yaowu Bai
    • Hongyuan Yang
  • View Affiliations

  • Published online on: April 28, 2023     https://doi.org/10.3892/etm.2023.11985
  • Article Number: 286
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The most common critical incidents in pediatric anesthesia are perioperative respiratory adverse events (PRAEs). The present meta‑analysis aimed to assess the preventive effect of dexmedetomidine on PRAEs in children. Dexmedetomidine is a highly selective α2‑adrenoceptor agonist that provides sedation, anxiolysis and analgesic effects without causing respiratory depression. Dexmedetomidine can diminish airway and circulatory responses during extubation in children. Original randomized controlled trial data were analyzed to study the putative effect of dexmedetomidine on PRAEs. By searched the Cochrane Library, EMBASE and PubMed, a total of ten randomized controlled trials (1,056 patients) was identified. PRAEs included cough, breath holding, laryngospasm, bronchospasm, desaturation (percutaneous oxygen saturation <95%), body movement and pulmonary rales. Compared with placebo, dexmedetomidine resulted in a significant reduction of incidence of cough, breath holding, laryngospasm and emergence agitation. The incidence of PRAEs was significantly reduced in dexmedetomidine compared with active comparators group. Moreover, dexmedetomidine decreased heart rate and increased post‑anesthesia care unit stay duration by 11.18 min. The present analysis suggested that dexmedetomidine improved the airway function and decreased risks associated with general anesthesia in children. The present data demonstrated that dexmedetomidine may be a good choice to prevent PRAEs in children.
View Figures
View References

Related Articles

Journal Cover

June-2023
Volume 25 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang J, Yin J, Li Y, Zhang Y, Bai Y and Yang H: Effect of dexmedetomidine on preventing perioperative respiratory adverse events in children: A systematic review and meta‑analysis of randomized controlled trials. Exp Ther Med 25: 286, 2023.
APA
Zhang, J., Yin, J., Li, Y., Zhang, Y., Bai, Y., & Yang, H. (2023). Effect of dexmedetomidine on preventing perioperative respiratory adverse events in children: A systematic review and meta‑analysis of randomized controlled trials. Experimental and Therapeutic Medicine, 25, 286. https://doi.org/10.3892/etm.2023.11985
MLA
Zhang, J., Yin, J., Li, Y., Zhang, Y., Bai, Y., Yang, H."Effect of dexmedetomidine on preventing perioperative respiratory adverse events in children: A systematic review and meta‑analysis of randomized controlled trials". Experimental and Therapeutic Medicine 25.6 (2023): 286.
Chicago
Zhang, J., Yin, J., Li, Y., Zhang, Y., Bai, Y., Yang, H."Effect of dexmedetomidine on preventing perioperative respiratory adverse events in children: A systematic review and meta‑analysis of randomized controlled trials". Experimental and Therapeutic Medicine 25, no. 6 (2023): 286. https://doi.org/10.3892/etm.2023.11985